Insurance
Legacy Claims - Heneghan v Manchester Dry Docks Ltd & Others (Court of Appeal)
15 février 2016
Our legacy and latent disease team comprises market leading experts
ur legacy and latent disease team includes specialists who have been involved in some of the most far reaching test litigation to occur in this field over the last 20 years.
We act as a valued partner to our clients that include major composite and runoff insurers, self-insured companies and multinationals with captive cover. Clients benefit from a partner led service where quality is assured as a result of a combination of technical expertise, supported by bespoke case management systems and management information provision.
Our team is recognised for delivering innovative strategies in handling both long-tail and short-tail claims to efficiently reduce the overall indemnity spend for our clients.
One of our key strengths is our global network of partners throughout our various offices who can advise on comparative law, litigation plus emerging risks and issues.
In addition to handling individual matters pre- and post-litigation we also handle group litigation, strategic litigation projects and advice on handling policies, government consultations and costs.
We adopt innovative approaches to market issues, in order to deliver excellent service and savings against indemnity spend. This includes our pioneering 'pay and be paid' mesothelioma claims handling scheme, Diffuse Pleural Thickening Asbestosis initiative and our strategic approach to immunotherapy.
Our areas of expertise include abuse, asbestos, asthma, autoimmune disorders, back injuries, cancer, carbon monoxide poisoning, carpal tunnel syndrome, chemical and biological agent exposure, chronic obstructive pulmonary disease, dermatitis, hand/arm vibration syndrome, hearing loss, pneumoconiosis, upper limb disorders and respiratory diseases, along with stress, bullying and statutory harassment claims. We also manage product liability class actions.